Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

HIV, the virus that causes AIDS, could be eliminated in Canada as early as 2030, if enough people at risk get tested and, if ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Treating obstructive sleep apnea in people living with HIV reduces fatigue and improves cardiovascular health, with similar ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Dr. Brandon Hill, CEO of Vivent Health and a researcher in HIV and sexual issues, talks about changes in government funding.

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...